Abstract
Introduction: People receiving haemodialysis experience a high symptom burden and impaired quality of life. The use of patient reported outcome measures (PROMs) is increasing in nephrology care, however their acceptability, utility and impacts are not well understood.
Methods and analysis: We describe a protocol for a qualitative study to evaluate the feasibility and acceptability of electronic-PROMs (e-PROMs) data capture and feedback in haemodialysis following the pilot Symptom monitoring WIth Feedback Trial (SWIFT). SWIFT involves linkage of ePROMs data, including symptoms and health-related quality of life, to the Australia and New Zealand Dialysis and Transplant Registry with feedback to patients’ treating nephrologists and nurse unit managers. Focus groups and semi-structured interviews will be conducted with nephrologists (n=15), dialysis nurses (n=24) and patients receiving haemodialysis (n=24) from six dialysis units in Australia. Question topics will include the technical and clinical feasibility and acceptability of e-PROMs reporting and feedback (including the barriers and enablers to uptake) and perceived impact on patient care and outcomes. Transcripts will be analysed thematically, and guided by Normalisation Process Theory.
Ethics and dissemination: Ethics approval was obtained from the relevant hospital Human Research Ethics Committees (HREC/18/CALHN/481; HREC/MML/54599). The findings from the SWIFT pilot and qualitative evaluation will inform the implementation of the SWIFT main trial, and more broadly, the use of ePROMs in clinical settings and registries.
Trial registration number: ANZCTRN12618001976279
Methods and analysis: We describe a protocol for a qualitative study to evaluate the feasibility and acceptability of electronic-PROMs (e-PROMs) data capture and feedback in haemodialysis following the pilot Symptom monitoring WIth Feedback Trial (SWIFT). SWIFT involves linkage of ePROMs data, including symptoms and health-related quality of life, to the Australia and New Zealand Dialysis and Transplant Registry with feedback to patients’ treating nephrologists and nurse unit managers. Focus groups and semi-structured interviews will be conducted with nephrologists (n=15), dialysis nurses (n=24) and patients receiving haemodialysis (n=24) from six dialysis units in Australia. Question topics will include the technical and clinical feasibility and acceptability of e-PROMs reporting and feedback (including the barriers and enablers to uptake) and perceived impact on patient care and outcomes. Transcripts will be analysed thematically, and guided by Normalisation Process Theory.
Ethics and dissemination: Ethics approval was obtained from the relevant hospital Human Research Ethics Committees (HREC/18/CALHN/481; HREC/MML/54599). The findings from the SWIFT pilot and qualitative evaluation will inform the implementation of the SWIFT main trial, and more broadly, the use of ePROMs in clinical settings and registries.
Trial registration number: ANZCTRN12618001976279
Original language | English |
---|---|
Article number | e039014 |
Number of pages | 7 |
Journal | BMJ Open |
Volume | 10 |
Issue number | 11 |
DOIs | |
Publication status | Published - 6 Nov 2020 |
Keywords
- Haemodialysis
- patient reported outcome measures
- symptom assessment
- quality of life
- qualitative research
- focus group
- interviews